Rhabdomyolysis and Metabolic Myopathy
Gene: ABHD5
A disorder of glycerolipid metabolism. Myopathy, identified through raised CK levels and muscle biopsy, was a commonly observed finding in 59% (86/147) cases with ABHD5 deficiency. The myopathy tends to generally be a slowly progressive muscle weakness and rarely culminates in cardiomyopathy.
Sources: Expert listCreated: 2 Jun 2023, 12:13 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Dorfman-Chanarin disease MONDO:0010155
Publications
Variants in this GENE are reported as part of current diagnostic practice
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Chanarin-Dorfman syndrome MIM#275630; neutral lipid storage disease with ichthyosis; non-bullous congenital ichthyosiform erithroderma
Publications
Gene: abhd5 has been classified as Green List (High Evidence).
Gene: abhd5 has been classified as Green List (High Evidence).
gene: ABHD5 was added gene: ABHD5 was added to Rhabdomyolysis and Metabolic Myopathy. Sources: Expert list Mode of inheritance for gene: ABHD5 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: ABHD5 were set to 31883530 Phenotypes for gene: ABHD5 were set to Dorfman-Chanarin disease MONDO:0010155 Review for gene: ABHD5 was set to GREEN gene: ABHD5 was marked as current diagnostic